Infections in travelers
PI(s)/Head responsible for the resource:
Tobias Allander
Host organisation(s):
Clinical Microbiology at Karolinska University Hospital
Resource description:
Correct diagnosis of infectious diseases is the foundation of infection control and surveillance. There are excellent diagnostic tools for common infections, but rare or unexpected infectious agents are more difficult to identify, and risk being missed. A more widespread use of unbiased diagnostic methods, such as metagenomic sequencing, would therefore improve surveillance and early identification of pandemic threats, including known and unknown pathogens.
With the support of PLP grants, we have developed a diagnostic metagenomic sequencing pipeline, which is now available for clinical diagnostic use. The main intended areas of use are severe, unexplained infections (CNS, respiratory or generalised), particularly cases when unusual pathogens are more likely, such as in immunosuppressed patients and travelers from tropical regions. A study evaluating the diagnostic yield in immunosuppressed patients with pneumonia is ongoing. The present study proposal aims for evaluation of metagenomic sequencing in patients suffering from febrile infections following travel in tropical countries.
The “Tropical fever study” at Karolinska University Hospital has included 521 patients seeking care for fever after travel in the tropics during 2017-2020. Approximately half of the cases lack etiological diagnosis. We will analyse an estimated 100 selected stored serum samples by metagenomic sequencing, with the aims to evaluate the diagnostic value of metagenomic sequencing of serum samples in this patient group, to identify additional causative microorganisms, and to describe the microbial genomes present in the serum of patients with fever of unknown etiology. We will also investigate paired acute and convalescent serum samples by a subtractive bioinformatic approach, to identify sequences associated with the disease episode independently from taxonomic classification.
Improved diagnosis of rare infections in travelers is important for early identification of pandemic threats.
Contact information:
Tobias Allander
Dept. of Clinical Microbiology, Karolinska University Hospital and Dept. of Microbiology, Tumor, and Cell Biology, Karolinska Institutet
Email: tobias.allander@regionstockholm.se